FindTrial
Sign In

Study to compare radiofrequency ablation and trichloroacetic acid (TCA) 50% chemical in xanthelasma patients.

A comparative study of radiofrequency ablation(RFA) with wound suturing versus trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrum. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079657
Enrollment
46
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Trichloroacetic acid (50%): trichloroacetic acid Dose-50% Frequency- once in two weeks Route - Topical application over the lesions Follow up- 2 weeks, 4 weeks and 6 weeks Duration of

Sponsors

Eras Lucknow Medical College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of Xanthelasma palpebrum presenting in the Dermatology OPD of Eras Lucknow Medical College.

Exclusion criteria

Exclusion criteria: 1) any active eyelid infection, eyelid eczema, keloidal tendency, patients with pacemaker, allergy to lidocaine, pregnant and lactating

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Radiofrequency ablation (RFA) with wound suturing versus Trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrumTimepoint: 0, 2, 4, 6 weeks—

Secondary

MeasureTime frame
To study and compare the side effects of Radiofrequency ablation (RFA) with wound suturing versus Trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrumTimepoint: 0, 2, 4, 6 weeks—

Countries

India

Contacts

Public ContactKetki

eras lucknow medical college and hospital

ketkilhmc@gmail.com9873701332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026